Synopsys Sees Unusually Large Options Volume (NASDAQ:SNPS)

Synopsys, Inc. (NASDAQ:SNPS) was the recipient of unusually large options trading on Wednesday. Stock investors bought 15,971 call options on the company. This is an increase of 169% compared to the average volume of 5,938 call options.

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Janet Lee sold 250 shares of Synopsys stock in a transaction on Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares of the company’s stock, valued at $6,338,270. The trade was a 2.05% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 4,157 shares of company stock worth $1,945,036 in the last 90 days. 0.62% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in SNPS. Lionshead Wealth Management LLC boosted its position in shares of Synopsys by 1.9% in the second quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock worth $469,000 after purchasing an additional 17 shares during the period. YANKCOM Partnership boosted its holdings in Synopsys by 3.3% in the 2nd quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock worth $275,000 after buying an additional 17 shares during the period. Manchester Capital Management LLC increased its stake in Synopsys by 5.3% in the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock worth $174,000 after buying an additional 17 shares in the last quarter. Savvy Advisors Inc. raised its holdings in Synopsys by 3.6% during the second quarter. Savvy Advisors Inc. now owns 551 shares of the semiconductor company’s stock valued at $282,000 after acquiring an additional 19 shares during the period. Finally, Advisors Capital Management LLC lifted its position in shares of Synopsys by 2.3% in the second quarter. Advisors Capital Management LLC now owns 862 shares of the semiconductor company’s stock valued at $442,000 after acquiring an additional 19 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Synopsys Price Performance

NASDAQ SNPS opened at $449.17 on Thursday. Synopsys has a 52 week low of $365.74 and a 52 week high of $651.73. The firm has a market capitalization of $86.04 billion, a P/E ratio of 56.22, a PEG ratio of 3.67 and a beta of 1.12. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The company has a 50-day moving average price of $472.85 and a 200-day moving average price of $479.02.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. The company had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm’s revenue was up 65.6% compared to the same quarter last year. During the same quarter last year, the firm posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Equities research analysts anticipate that Synopsys will post 10.64 earnings per share for the current year.

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Q1 beat and strong results — Synopsys reported non‑GAAP EPS of $3.77 and revenue of $2.409B, topping estimates and showing strong year‑over‑year growth; the quarter came at the high end of prior guidance. PR Newswire: Q1 Results
• Positive Sentiment: Very bullish guidance — management raised FY26 EPS guidance to $14.38–$14.46 and Q2 EPS guidance to $3.11–$3.17, well above Street estimates, which is driving optimism about near‑term earnings power. Guidance/Press Release
• Positive Sentiment: Capital return boost — the board authorized up to $2.0B in additional share repurchases, which supports EPS and signals confidence from management. Buyback Announcement
• Positive Sentiment: Analyst and market interest — Morgan Stanley reiterated a Buy and noted strong earnings quality and IP trajectory; unusual call‑option buying also points to bullish trader positioning. TipRanks: Morgan Stanley Buy
• Neutral Sentiment: Mixed near‑term revenue signal — while EPS guidance was raised, quarterly revenue guidance landed roughly in line with expectations, suggesting upside is currently EPS‑driven rather than revenue surprise. Guidance Details
• Negative Sentiment: China export restrictions and muted next‑quarter outlook — Reuters flagged Synopsys forecasting a more muted quarter amid China export limits and macro uncertainty, which pressured the stock earlier and could cap upside if geopolitical risk persists. Reuters: China Export Restrictions
• Negative Sentiment: Leverage concerns from M&A — commentators note Synopsys carries large incremental debt (post‑deal) that investors are watching closely; higher leverage raises sensitivity to execution and could limit valuation expansion. 24/7 Wall St.: Debt Concerns

Analysts Set New Price Targets

Several brokerages recently weighed in on SNPS. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and reduced their price target for the company from $525.00 to $500.00 in a research report on Monday, December 8th. Rosenblatt Securities reissued a “buy” rating and issued a $560.00 target price on shares of Synopsys in a report on Friday, February 20th. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Wells Fargo & Company increased their price objective on Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a research report on Thursday, December 11th. Finally, Needham & Company LLC boosted their target price on Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Nine analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $547.00.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.